These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4350595)

  • 21. Hypertension of renal origin: evidence for two different mechanisms.
    Brunner HR; Kirshman JD; Sealey JE; Laragh JH
    Science; 1971 Dec; 174(4016):1344-6. PubMed ID: 4332626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chemistry and mechanism of new angiotensin UU antagonists: 8 C-phenylclycine analogues of [5-isoleucine] angiotensin].
    Wissmann H; Schoelkens B; Lindner E; Geiger R
    Hoppe Seylers Z Physiol Chem; 1974 Sep; 355(9):1083-96. PubMed ID: 4376799
    [No Abstract]   [Full Text] [Related]  

  • 23. Evidence for a significant contribution from central effects of angiotensin in the development of acute renal hypertension in the greyhound.
    Scoop GC; Katic FP; Brown MJ; Cain MD; Zeegers PJ
    Clin Sci Mol Med; 1975 Feb; 48(2):115-9. PubMed ID: 1116331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of angiotensin antagonists in various forms of experimental arterial hypertension.
    Ferrario CM; Bumpus FM; Masaki Z; Khosla MC; McCubbin JW
    Prog Biochem Pharmacol; 1976; 12():86-97. PubMed ID: 1019172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The inhibition of angiotensin converting enzyme in chronic renal hypertension by a synthetic peptide.
    Loyke HF
    Proc Soc Exp Biol Med; 1975 Nov; 150(2):457-60. PubMed ID: 174133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Editorial: Angiotensin inhibition.
    Chobanian AV
    N Engl J Med; 1974 Oct; 291(16):844-5. PubMed ID: 4371423
    [No Abstract]   [Full Text] [Related]  

  • 27. Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a nonpeptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibody.
    Wong PC; Price WA; Reilly TM; Duncia JV; Timmermans PB
    J Pharmacol Exp Ther; 1989 Aug; 250(2):515-22. PubMed ID: 2668502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experimental, acute renal hypertension and exogenous angiotensin II administration following premedication with the prostaglandin biosynthesis inhibitor indometacin].
    Schölkens BA
    Verh Dtsch Ges Inn Med; 1974; 80():285-8. PubMed ID: 4375905
    [No Abstract]   [Full Text] [Related]  

  • 29. Cardiovascular effects of microinjection of angiotensin II in the brainstem of renal hypertensive rats.
    Mosqueda-Garcia R; Tseng CJ; Appalsamy M; Robertson D
    J Pharmacol Exp Ther; 1990 Oct; 255(1):374-81. PubMed ID: 2213569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Angiotensin and its vasopressive action. II. Action of angiotensin in normal and hypertensive humans].
    Schwartz J; Bloch R; Desaulles F; Imbs JL
    Pathol Biol; 1967; 15(11):653-6. PubMed ID: 4292972
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative pharmacology of new specific angiotensin antagonists.
    Schoelkens BA
    Clin Sci Mol Med Suppl; 1975 Jun; 2():19s-21s. PubMed ID: 1077769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for angiotensin-induced hypertension.
    Lancet; 1971 Feb; 1(7693):277-8. PubMed ID: 4100023
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of angiotensin on the renal transport of sodium in arterial hypertension].
    Villarreal H
    Arch Inst Cardiol Mex; 1977; 47(3):365-72. PubMed ID: 921392
    [No Abstract]   [Full Text] [Related]  

  • 35. Infusion of angiotensin-II analogue in two patients with unilateral renovascular hypertension.
    Donker AJ; Leenen FH
    Lancet; 1974 Dec; 2(7896):1535-7. PubMed ID: 4140980
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies of the renal component of the hypertension in rats with aortic constriction. Role of angiotensin II.
    Sahlgren B; Eklöf AC; Aperia A
    Acta Physiol Scand; 1986 Aug; 127(4):443-8. PubMed ID: 3529826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical applications of synthetic angiotensin II analogue.
    Ogihara T; Yamamoto T; Kumahara Y
    Jpn Circ J; 1974 Nov; 38(11):997-1003. PubMed ID: 4373592
    [No Abstract]   [Full Text] [Related]  

  • 38. Agents which block the action of the renin-angiotensin system.
    Davis JO; Freeman RH; Johnson JA; Spielman WS
    Circ Res; 1974 Mar; 34(3):279-85. PubMed ID: 4362035
    [No Abstract]   [Full Text] [Related]  

  • 39. Angiotensin blocking actions of guancydine.
    Cummings JR; Welter AN; Grace JL; Gray WD
    J Pharmacol Exp Ther; 1969 Dec; 170(2):334-46. PubMed ID: 4311323
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of angiotensen antagonist in rats with acute, subacute, and chronic two-kidney renal hypertension.
    Carretero OA; Gulati OP
    J Lab Clin Med; 1978 Feb; 91(2):264-71. PubMed ID: 621427
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.